Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EGF Theramed HealthEVAHF EV-to-EBITDA is -10.34 as of Jul. 31, 2026. The stock has 3 warning signs investors should review. Among 509 Healthcare Providers & Services companies, EGF Theramed Health ranks worse than 196463.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, EGF Theramed Health's enterprise value is $0.76 Mil.
EGF Theramed Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.07 Mil. Therefore, EGF Theramed Health's EV-to-EBITDA for today is -10.34.
The historical rank and industry rank for EGF Theramed Health's EV-to-EBITDA or its related term are showing as below:
EVAHF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.41 Med: 0 Max: 0
Current: -10.41
EVAHF's EV-to-EBITDA is ranked worse than 100% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.04
vs EVAHF: -10.41
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EGF Theramed Health (OTCPK:EVAHF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EGF Theramed Health's PE Ratio (TTM) for today is calculated as:
EGF Theramed Health's share price for today is $0.03.
EGF Theramed Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.200.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for EGF Theramed Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, EGF Theramed Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EGF Theramed Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EGF Theramed Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where EGF Theramed Health's EV-to-EBITDA falls into.
EGF Theramed Health's current Enterprise Value is $0.76 Mil.
EGF Theramed Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EGF Theramed Health (EVAHF) has a EV-to-EBITDA of -10.34 as of Jul. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on EGF Theramed Health. According to the industry distribution chart, EGF Theramed Health ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is EGF Theramed Health's EV-to-EBITDA too high?
EGF Theramed Health's current EV-to-EBITDA is -10.34. Based on the distribution chart, EGF Theramed Health ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does EGF Theramed Health's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EGF Theramed Health ranks #999999 out of 509 companies for EV-to-EBITDA. This places EGF Theramed Health in the lower half of its industry. The industry median EV-to-EBITDA is 11.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on EGF Theramed Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EGF Theramed Health's current EV-to-EBITDA is -10.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EGF Theramed Health stock overvalued right now?
EGF Theramed Health (EVAHF) has a current EV-to-EBITDA of -10.34. The current EV-to-EBITDA is -10.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For EGF Theramed Health (EVAHF), the current EV-to-EBITDA is -10.34 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. It explores many other medical areas including weight loss, skincare and heart disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVAHF has been successfully added to your 
